Alvarez, Edgardo A.
HRN: 26-62-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2025
CEFUROXIME 750MG (VIAL)
10/03/2025
10/10/2025
IVT
260mg
Q8
AGE With Moderate Dehydration; URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTIIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes